FCCC LOGO Faculty Publications
Ettinger DS , Wood DE , Aisner DL , Akerley W , Bauman JR , Bharat A , Bruno DS , Chang JY , Chirieac LR , D'Amico TA , Dilling TJ , Dowell J , Gettinger S , Gubens MA , Hegde A , Hennon M , Lackner RP , Lanuti M , Leal TA , Lin J , Loo BW Jr , Lovly CM , Martins RG , Massarelli E , Morgensztern D , Ng T , Otterson GA , Patel SP , Riely GJ , Schild SE , Shapiro TA , Singh AP , Stevenson J , Tam A , Yanagawa J , Yang SC , Gregory KM , Hughes M
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021
J Natl Compr Canc Netw. 2021 Mar 2;19(3) :254-266
Back to previous list
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.
Notes
1540-1413 Ettinger, David S Wood, Douglas E Aisner, Dara L Akerley, Wallace Bauman, Jessica R Bharat, Ankit Bruno, Debora S Chang, Joe Y Chirieac, Lucian R D'Amico, Thomas A Dilling, Thomas J Dowell, Jonathan Gettinger, Scott Gubens, Matthew A Hegde, Aparna Hennon, Mark Lackner, Rudy P Lanuti, Michael Leal, Ticiana A Lin, Jules Loo, Billy W Jr Lovly, Christine M Martins, Renato G Massarelli, Erminia Morgensztern, Daniel Ng, Thomas Otterson, Gregory A Patel, Sandip P Riely, Gregory J Schild, Steven E Shapiro, Theresa A Singh, Aditi P Stevenson, James Tam, Alda Yanagawa, Jane Yang, Stephen C Gregory, Kristina M Hughes, Miranda Journal Article United States J Natl Compr Canc Netw. 2021 Mar 2;19(3):254-266. doi: 10.6004/jnccn.2021.0013.